Stockscreener 앱 받기
10.38
1.69%
-0.2282
Biohaven Ltd 주식(BHVN)의 최신 뉴스
TD Asset Management Inc Cuts Stake in Biohaven Ltd. $BHVN - MarketBeat
Biohaven stock price target lowered to $10 by H.C. Wainwright - Investing.com South Africa
Biohaven (NYSE:BHVN) Given New $10.00 Price Target at HC Wainwright - MarketBeat
BHVN Earnings History & Surprises | EPS & Revenue Results | BIOHAVEN LTD (NYSE:BHVN) - ChartMill
Assessing Biohaven (BHVN) Valuation After Recent Share Price Volatility - simplywall.st
Biohaven Reshapes Pipeline And Funding As Late Stage Trials Approach - Yahoo Finance
Biohaven (BHVN) VP and CAO awarded 50,000 stock options with 4-year vesting - Stock Titan
Biohaven (BHVN) CFO awarded 175,000 stock options in Form 4 filing - Stock Titan
Biohaven Ltd. (BHVN) SVP awarded 175,000 stock options with 4-year vesting - Stock Titan
Biohaven (BHVN) Chief Scientific Officer awarded 175,000 stock options - Stock Titan
Biohaven (BHVN) CEO Vlad Coric granted 550,000 stock options - Stock Titan
Key facts: Biohaven posts $738.8M loss; opakalim shows promise in study; analysts give 'buy' rating - TradingView
Biohaven (NYSE:BHVN) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - MarketBeat
Piper Sandler reiterates Biohaven stock rating on 2026 catalysts By Investing.com - Investing.com Canada
Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 77% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Piper Sandler reiterates Biohaven stock rating on 2026 catalysts - Investing.com
RBC Raises Price Target on Biohaven to $23 From $22, Keeps Outperform, Speculative Risk - marketscreener.com
JPMorgan Chase & Co. Reduces Stake in Biohaven Ltd. $BHVN - MarketBeat
Biohaven Ltd. Common Shares (NY: BHVN - The Chronicle-Journal
Biohaven Ltd reports results for the quarter ended September 30Earnings Summary - TradingView
Biohaven (NYSE:BHVN) Announces Earnings Results - MarketBeat
Biohaven (NYSE: BHVN) refocuses pipeline after key trial and FDA setbacks - Stock Titan
Earnings Flash (BHVN) Biohaven Ltd. Posts Q4 Adjusted Loss $0.90 per Share, vs. FactSet Est of $-0.87 - marketscreener.com
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results - PR Newswire
How US$600 Million Non-Dilutive Funding and R&D Cuts Will Impact Biohaven (BHVN) Investors - Sahm
Biohaven Ltd. (BHVN): A Bull Case Theory - Yahoo Finance
BHVN Should I Buy - Intellectia AI
Assessing Biohaven (BHVN) Valuation After A Sharp One Year Decline And Recent Three Month Rebound - simplywall.st
Biohaven Ltd. (NYSE:BHVN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Biohaven Ltd. (BHVN) Stock Analysis: Navigating a Potential 80% Upside in the Biotechnology Sector - DirectorsTalk Interviews
Trading the Move, Not the Narrative: (BHVN) Edition - Stock Traders Daily
Biohaven (BHVN) Projected to Post Earnings on Monday - MarketBeat
Is Biohaven Ltd. stock a good pick for beginnersWeekly Trade Report & Expert Curated Trade Setup Alerts - mfd.ru
Biohaven Ltd. (BHVN) Stock Analysis: A Biotech Challenger With An 84% Potential Upside - DirectorsTalk Interviews
Raymond James Begins Coverage of Biohaven with Strong Buy Rating and Sets Price Target at $75 - Intellectia AI
What catalysts could drive Biohaven Ltd. stock higherTrade Exit Summary & Real-Time Volume Analysis - mfd.ru
Biohaven CEO Vlad Coric to Present at J.P. Morgan Healthcare Conference on January 12, 2026 - Intellectia AI
Biohaven Reveals Pricing for $175 Million Public Offering of Common Stock - Intellectia AI
Aug Drivers: Is Biohaven Ltd. in a bullish channelWeekly Trend Recap & Safe Entry Trade Reports - mfd.ru
'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments - Fierce Biotech
(BHVN) Volatility Zones as Tactical Triggers - Stock Traders Daily
Biohaven Stock Surges 8.4% After Analyst Upgrade - National Today
Assessing Biohaven (BHVN) Valuation As Analyst Optimism And Earnings Estimates Improve - simplywall.st
RSI Check: Can Biohaven Ltd deliver alpha2025 Technical Patterns & Expert Verified Movement Alerts - baoquankhu1.vn
Biohaven Ltd. (BHVN): Analyst Consensus Points to 63% Upside Potential Amidst Biotech Innovation - DirectorsTalk Interviews
Does Biohaven Ltd. (BHVN) have the potential to rally 82.16% as Wall Street analysts expect? - MSN
Big Money Moves: What are analysts price targets for Biohaven LtdWall Street Watch & Detailed Earnings Play Strategies - baoquankhu1.vn
Is Biohaven Ltd. (BHVN) stock outpacing its medical peers this year? - MSN
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Biohaven (NYSE:BHVN) Stock Price Up 8.4%Should You Buy? - MarketBeat
Does Biohaven Ltd. (BHVN) Have the Potential to Rally 82.16% as Wall Street Analysts Expect? - Finviz
Goldman Sachs initiates coverage on Biohaven Pharma stock with Buy rating - Investing.com Australia
Published on: 2026-02-06 01:35:19 - baoquankhu1.vn
Breakout Zone: What are analysts price targets for Biohaven LtdPortfolio Update Report & Smart Investment Allocation Insights - baoquankhu1.vn
Biohaven Ltd. (BHVN) Stock Analysis: Exploring A 77% Potential Upside For Investors - DirectorsTalk Interviews
Wall Street analysts predict an 88.57% upside in Biohaven Ltd. (BHVN): Here's what you should know - MSN
Price-Driven Insight from (BHVN) for Rule-Based Strategy - Stock Traders Daily
Aug Closing: Can Biohaven Ltd be recession proofWeekly Market Outlook & AI Driven Price Forecasts - baoquankhu1.vn
Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 63% Upside Potential in Biotech Innovation - DirectorsTalk Interviews
0.50%
자본화:
|
볼륨(24시간):